Express Pharma

Generative AI: Strategies for a Competitive Advantage

0 117

The advent of generative AI holds the promise of revolutionizing productivity in both human and business terms. However, organizations face significant challenges in creating a GenAI strategy, such as integrating the technology into existing systems, ensuring compliance with evolving regulations and overcoming skill scarcity.

A new global survey of 1,600 organizations revealed key insights into the benefits and challenges companies are facing. Of these organizations, 54% have begun to implement GenAI and 86% are planning to invest in the technology in the next financial year. Where does your organization fall? Read the report for insights and practical guidelines.

You will learn the strategic investments companies are making to harness the unparalleled potential of GenAI and how to identify leading GenAI use cases to deliver speedy return on investment. Find out which data and AI tools can help identify potential biases in the raw data used to feed LLMs.

Also, discover how you can facilitate measurable outcomes with GenAI and decisioning workflow systems and how to prepare your organization in an era of exciting change proactively. And learn which regions and industries are thriving, and which are moving more slowly compared to the rest of the market.

 

    I would like to be contacted by SAS representative.
    Yes, I would like to receive email updates about SAS products, services and events.
    For full details of how we will treat your information please view our privacy policy: SAS Privacy Policy

    This is co-hosted by Express Pharma and SAS

    By submitting this form, you are confirming you are an adult 18 years or older and agree to Express Pharma contacting you with marketing-related emails or by telephone. You may unsubscribe from receiving such communications from Express Pharma at any time. Express Pharma web sites and communications are subject to our Privacy Notice and Terms of Use.


    Leave A Reply

    Your email address will not be published.